FDA Launches Global Rx Quality Initiative With Plans To Rely On Non-U.S. Regulators
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency restructures staff as it prepares for new U.S.-EU mutual reliance activities to enhance pharmaceutical quality but offers few details on upcoming plans.
You may also be interested in...
US-EU Mutual Reliance On Drug Facility Inspections Nears Reality
FDA expects to complete work this year on decision model to determine whether an EU member state's inspectorate is capable of conducting inspections that meet US requirements.
US-EU Mutual Reliance On Drug Facility Inspections Nears Reality
FDA expects to complete work this year on decision model to determine whether an EU member state's inspectorate is capable of conducting inspections that meet US requirements.
FDA/EU Mutual Reliance For GMP Inspections Moving Forward
Both sides may agree to overlook “areas of divergence” if they don’t appear significant.